SCHEMBL10189674

SCHEMBL10189674

Nc1nc(N)c(C(=O)/N=C2\NCC3(CCN(C(=O)Cc4ccc(O)cc4)CC3)N2)nc1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCNN1A P37088 6/20 0.38
ME2 P23368 4/20 0.37
ME1 P48163 4/20 0.37
ME3 Q16798 4/20 0.37
HSD11B1 P28845 1/20 0.34
HSD17B10 Q99714 4/20 0.33
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 3/20 0.33
GLA P06280 3/20 0.33
HPGD P15428 3/20 0.33
CYP1A2 P05177 3/20 0.33
LMNA P02545 2/20 0.33
GAA P10253 2/20 0.33
PLAU P00749 2/20 0.33
CYP2D6 P10635 2/20 0.33
TSHR P16473 2/20 0.33
SLC22A1 O15245 1/20 0.33
HTR1A P08908 1/20 0.33
SLC9A1 P19634 1/20 0.33
MAOA P21397 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1684559 0.92 OPRD1 (0.40) SCNN1AHSD17B10KDM4EALDH1A1GLA
SCHEMBL1684543 0.92 SCNN1A (0.41) SCNN1AME2ME1ME3HSD17B10
SCHEMBL1586606 0.89 SCNN1A (0.34) SCNN1AHSD11B1HSD17B10KDM4EALDH1A1
SCHEMBL2126510 0.89 NPC1 (0.35) SCNN1AME2ME1ME3HSD11B1
SCHEMBL1684512 0.88 KCNH2 (0.42) GAAPLAUOPRD1TP53
SCHEMBL12215593 0.87 GHSR (0.36) SCNN1AHSD17B10ALDH1A1HPGDCYP1A2
SCHEMBL1684677 0.87 SCNN1A (0.34) SCNN1AHSD17B10KDM4EALDH1A1GLA
SCHEMBL12215560 0.86 ALDH1A1 (0.38) SCNN1AHSD17B10KDM4EALDH1A1GLA
SCHEMBL2142417 0.86 SCNN1A (0.37) SCNN1APANK3OPRD1
SCHEMBL13321376 0.85 GHSR (0.37) SCNN1APANK3OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2520574-A1 Amiloride analogues substituted on the cyclic guanidine moiety as ENaC blockers for treating respiratory diseases Novartis AG (CH) 2012-11-07 EP disclosed
EP-2444120-A1 Spirocyclic amiloride analogues as ENac blockers Novartis AG (CH) 2012-04-25 EP disclosed